Premium
Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates
Author(s) -
Cantón Rafael,
Valdezate Sylvia,
Vindel Ana,
Sánchez Del Saz Begoña,
Maíz Luis,
Baquero Fernando
Publication year - 2003
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.10216
Subject(s) - stenotrophomonas maltophilia , microbiology and biotechnology , ticarcillin , aztreonam , medicine , agar dilution , ceftazidime , cystic fibrosis , trovafloxacin , minimum inhibitory concentration , antibacterial agent , antimicrobial , imipenem , antibiotics , biology , pseudomonas aeruginosa , antibiotic resistance , bacteria , genetics
Multiresistance in Stenotrophomonas maltophilia limits the effectiveness of antimicrobial therapy for infections due to this organism. It can be of special concern in cystic fibrosis (CF) patients due to frequent antimicrobial administration. The in vitro activity of 41 antimicrobial agents against 76 epidemiologically defined CF S. maltophilia isolates by pulsed‐field‐gel electrophoresis (PFGE) technique under Xba I and Spe I restriction was compared with that obtained with 51 non‐CF strains recovered from respiratory sources. Minimal inhibitory concentrations (MICs) were determined with the standard National Committee for Clinical Laboratory Standards agar dilution technique, but with 24‐hr incubation. Forty‐seven different PFGE profiles were observed within 76 S. maltophilia CF isolates. Minocycline (resistance rate, 0%; MIC 90 , 1 μg/ml), doxycycline (6.4%; 8 μg/ml), trovafloxacin (4.2%; 2 μg/ml), moxifloxacin (6.3%; 2 μg/ml), clinafloxacin (6.3%; 2 g/ml), and moxalactam (17.0%; 64 g/ml) displayed low resistance rates. On the contrary, resistance rates were higher with ceftazidime (70.0%; 256 μg/ml), cefepime (83.0%; 128 μg/ml), piperacillin (87.2%; >1,024 μg/ml), ticarcillin (87.2%; >512 μg/ml), and aztreonam (95.7%; >1,024 μg/ml). Clavulanate reverted resistance to ticarcillin and aztreonam in 40.4% and 31.7% of strains, respectively. Aminoglycosides displayed reduced activities with susceptibility rates lower than 20% and MIC 90 higher than 128 μg/ml. With the exception of trimethoprim‐sulfamethoxazole (25.4 vs. 31.3%), CF isolates were more resistant than non‐CF isolates. Remarkably, resistance was enhanced in S. maltophilia isolates persistently recovered in chronically colonized patients. Susceptibility analysis demonstrated higher resistance rates among CF S. maltophilia isolates when compared with respiratory isolates from non‐CF patients. Moreover, persistently recovered CF S. maltophilia isolates were more resistant than sporadic non‐CF isolates. Pediatr Pulmonol. 2003; 35:99–107. © 2003 Wiley‐Liss, Inc.